Welcome Visitor Wednesday, November 13, 2019

Articles related to Pathfinder Therapeutics


Centerstone Research Institute eyes capital for healthcare analytics spin-out
Centerstone Research Institute eyes capital for healthcare analytics spin-out

Centerstone of America seeks commercial prowess to get technologies to market.

Read More
LaunchTN's Gindt departs to lead LinkdCare healthcare startup
LaunchTN's Gindt departs to lead LinkdCare healthcare startup

[updated] Stefansic and Hogin among those departing, with interest in private-sector jobs.

Read More
Nashville pioneer Pathfinder Technologies moving to sell to Analogic
Nashville pioneer Pathfinder Technologies moving to sell to Analogic

After a decade widening Nashville's lifesciences entrepreneurship, a strategic move.

Read More
LaunchTN appoints commercialization director from Nashville startup ranks
LaunchTN appoints commercialization director from Nashville startup ranks

TTDC now seems to be fully staffed to further pro-venture programs

Read More
Gov. Haslam's INCITE program stirs to life via 'Venture Incite' A-round
Gov. Haslam's INCITE program stirs to life via 'Venture Incite' A-round

There are some new faces among the 'usual suspects' applying at INCITE Fund

Read More
'Educating the money' may be answer to diversifying Nashville techventures
'Educating the money' may be answer to diversifying Nashville techventures

[EMIDS update Dec. 5, 2013] Maybe it's time to focus on something more than our reported shortage of coders

Read More
Noted: Pathfinder Therapeutics has named Jim Cloar president, CEO
Noted: Pathfinder Therapeutics has named Jim Cloar president, CEO
The latest CEO appointment at the helm of Pathfinder has a med-devices background.
Read More
TechVenture Challenge spurs entrepreneurism<br>among Vanderbilt University students
TechVenture Challenge spurs entrepreneurism
among Vanderbilt University students

Students have decided they can't wait on the rest of the world to create the great jobs they want

Read More
Angel Capital Group chapter fate uncertain in Memphis
Angel Capital Group chapter fate uncertain in Memphis

ACG plans to open five new city chapters soon; for now, its Memphis outpost is semi-shuttered

Read More
NewsBits, Sept. 20, 2011
NewsBits, Sept. 20, 2011

Executive transitions, capital raises, alliances and innovations.

Read More
TNInvestco portfolios: Hapten, ConsensusPoint, iScreen, Cagenix updates
TNInvestco portfolios: Hapten, ConsensusPoint, iScreen, Cagenix updates
Reports from the front lines of entrepreneurship keep trickling in
Read More
Vanderbilt University picks Cleveland Clinic exec<br>to drive transfer and commercialization of IP
Vanderbilt University picks Cleveland Clinic exec
to drive transfer and commercialization of IP
' Overhaul and investment ' could lead to accelerated enterprise development from VU research and development
Read More
TNInvestco: Welcome to the 'Messy World' of Capitalism
TNInvestco: Welcome to the 'Messy World' of Capitalism
Airing of issues simmering beneath TNInvestco's surface has prompted a reprise of comments pro and con the program
Read More
VU School of Engineering alumni spawn businesses
VU School of Engineering alumni spawn businesses
It may be only the tip of the Engineering iceberg at Vanderbilt, but here's a sample of the fruits of education and research
Read More
Pathfinder's Stefansic comments on Nashville leverage, challenges
Pathfinder's Stefansic comments on Nashville leverage, challenges
Quiet figure behind the scenes of a Vanderbilt-spawned startup steps forward with observations and appreciation
Read More
Vanderbilt venture developer notes 'disconnect' with Venture Capital
Vanderbilt venture developer notes 'disconnect' with Venture Capital
Christopher Rand's presentation underscores gaps in the capital continuum, but suggests a target-rich environment for seed-stage investors
Read More
CredenceHealth leverages Angel money and Feds' pressure
CredenceHealth leverages Angel money and Feds' pressure

With $17.2 billion soon under the scalpel, startup feels it has a better mousetrap for improving quality and financial returns

Read More
VC CEO steps aside for new man at Pathfinder Therapeutics
VC CEO steps aside for new man at Pathfinder Therapeutics
UPDATED 12:44 p.m.Nationwide search lands med-devices veteran for persistent Vanderbilt spin-out
Read More
Nashville tech ventures to pitch at Southeast Venture Conference
Nashville tech ventures to pitch at Southeast Venture Conference
Two very different enterprises - Uloop and Pathfinder Therapeutics - are on the money trail, once again
Read More
Vanderbilt steps-up effort to help faculty create ventures, market products
Vanderbilt steps-up effort to help faculty create ventures, market products
Hundreds of discoveries and patents on-hand, Vanderbilt expands its efforts to commercialize intellectual property
Read More
Pathfinder Therapeutics gets $5.2MM A-round infusion
Pathfinder Therapeutics gets $5.2MM A-round infusion
After a long sojourn in the VC desert, a VU spinout finds it A-round lead in North Carolina
Read More
Pathfinder Therapeutics CEO is out
Pathfinder Therapeutics CEO is out
Venture continues to scout capital, relying on federal grants to stay alive and hoping for a break
Read More
UPDATE:  Pathfinder Therapeutics is back on the money trail
UPDATE: Pathfinder Therapeutics is back on the money trail
Making scientific discoveries that can survive the punishing path toward the market is hard enough. Now that the FDA has approved marketing that could save liver-cancer patients' lives, Pathfinder Therapeutics hopes local investors and the State of Tennessee can lend a hand. But, they're not holding their breath.
Read More
VU Tech Transfer takes company's liquidation in stride
VU Tech Transfer takes company's liquidation in stride

There are still 21 active portfolio companies over which Chris McKinney says grace.

Read More

Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: